Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Prebiotics composition

The technology of a composition and a pharmaceutical preparation is applied in the field of compositions comprising stachyose and galactooligosaccharide as effective active ingredients, which can solve the problems of less stachyose and the like, and achieve complete bacterial species, better bacterial species, and better probiotics. effect of effect

Active Publication Date: 2015-05-27
北京同泽康成医疗科技有限公司
View PDF10 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0026] There are few studies on stachyose in the prior art, and there are no relevant reports on the combination of stachyose and galactooligosaccharides at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prebiotics composition
  • Prebiotics composition
  • Prebiotics composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Pass stachyose and galacto-oligosaccharide through a 100-mesh sieve respectively, weigh 1,000 grams of stachyose and 3,000 grams of galacto-oligosaccharide, mix them evenly, and pack them into 1,000 bags, preferably in aluminum-plastic packaging.

Embodiment 2

[0055] Weigh 3,000 grams of stachyose and 1,000 grams of galacto-oligosaccharide, mix with appropriate amount of dextrin, granulate with 85% ethanol, dry and pack into 1,000 bags, preferably aluminum-plastic packaging.

Embodiment 3

[0057] Weigh 1 gram of stachyose and 10 grams of galactooligosaccharides, dissolve them in a small amount of distilled water and add them to various creams.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a composition for adjusting intestinal microecology of a human body. The composition comprises stachyose and galactooligosaccharides as active ingredients. The composition provided by the invention can be used for effectively adjusting the intestinal bacteria community function.

Description

technical field [0001] The invention relates to a composition for regulating human intestinal microecology, in particular to a composition comprising stachyose and galacto-oligosaccharide as effective active ingredients. Background technique [0002] The number of microbial cells carried by the human body is as many as trillions, and these huge symbiotic microbial groups are mainly distributed in the skin, oral cavity and gastrointestinal tract of the human body, among which the intestinal tract is the most concentrated part of microorganisms. Experiments have confirmed that the intestinal flora plays a vital role in the nutrition, metabolism and immune function of the host, is very important for maintaining human health, and is an indispensable part of realizing the normal physiological functions of the host. [0003] In the human microecological system, the intestinal microecology is the main and most active one, which has a significant impact on human health. Intestinal ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L1/09A61K31/702A61P1/12A61P15/02A61P37/02A61P37/08A61P3/06A61P35/00A61P19/10A61P1/00A23L33/125
Inventor 骆奇苑可武朱红滨佟倩
Owner 北京同泽康成医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com